Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 3
1 (100.0%)Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Ocumension Therapeutics (Suzhou) Co., Ltd
- Target Recruit Count
- 148
- Registration Number
- NCT06697522
- Locations
- π¨π³
Beijing Children's Hospital, Capital Medical University, Beijing, China
News
No news found